Topography of the GLP-1/GLP-1 receptor system in the spinal cord of male mice

Abstract Glucagon-like peptide-1 receptor (GLP-1R) agonists are now commonly used to treat type 2 diabetes and obesity. GLP-1R signaling in the spinal cord has been suggested to account for the mild tachycardia caused by GLP-1R agonists, and may also be involved in the therapeutic effects of these d...

Description complète

Détails bibliographiques
Auteurs principaux: Yvette Ruska, Andrea Csibi, Beáta Dorogházi, Anett Szilvásy-Szabó, Petra Mohácsik, Zsuzsanna Környei, Ádám Dénes, Andrea Kádár, Zita Puskár, Erik Hrabovszky, Balázs Gereben, Gábor Wittmann, Csaba Fekete
Format: Article
Langue:English
Publié: Nature Portfolio 2024-06-01
Collection:Scientific Reports
Accès en ligne:https://doi.org/10.1038/s41598-024-65442-1